| Name | Title | Contact Details |
|---|
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
KeyMedical Software is a Lebanon, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clin-X, comprised of three affiliated companies (ClinEdge, BTC Network, and GuideStar Research), provides a full range of clinical and outsourced business services to clinical research institutions, hospitals, pharmaceutical companies, and CROs. Combined, the companies represent four business segments: two global networks of research clinics, consulting and financial management, and patient recruitment and retention. The business segments seamlessly work together to streamline research operations, minimize enrollment timelines, and overall help research institution businesses thrive.
Established 25 years ago, Coordinated Health is a privately held, physician-owned, specialized hospital network delivering an accessible, affordable and fully integrated continuum of care in eastern Pennsylvania and western New Jersey. Our more than 70 physicians and our full 1,200-member team focus on many healthcare specialties. Coordinated Health is the only hospital in Lehigh Valley to achieve the Top Performer rating from The Joint Commission for three consecutive years. The company has repeatedly earned the highest patient satisfaction scores from the Centers for Medicare and Medicaid Services and the lowest infection rates from one of the country’s leading consumer advocacy groups. In 2014, Coordinated Health was the only hospital in its area to receive the annual Healthgrades Patient Safety Excellence Award.
Established in 2005, Butterfly Effects is one of the nation`s leading providers of individually tailored community-based ABA (Applied Behavior Analysis) therapy services for all ages of individuals with autism and other related disabilities. We help children and adults at all development levels, and assist families in instilling positive, lasting changes for their loved ones.